| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 8, 2014Grants Help Mark Five Years Since Diabetes Therapy Management and Education Center Opened its Doors
SAN ANTONIO, TX - December 8, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that five San Antonio community organizations will receive a combined $250,000 in Health Access Grants in...
-
Dec 8, 2014Medtronic Philanthropy Program Honors Ten Individuals Around the World with $20,000 Charitable Grants to Their Causes
MINNEAPOLIS - December 8, 2014 - Medtronic (NYSE: MDT) today announced the names of 10 people from around the world who will be honored as part of the Bakken Invitation, a global program launched...
-
Dec 5, 2014
MINNEAPOLIS - Dec 5, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 25th Annual Oppenheimer Healthcare Conference on...
-
Dec 5, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 5, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Dec 4, 2014"Delivering Societal Value through Responsible Growth" Reviews Company's Economic, Social and Environmental Performance for Fiscal Year 2014
MINNEAPOLIS - Dec. 3, 2014 - Medtronic, Inc. (NYSE:MDT) has released "Delivering Societal Value through Responsible Growth," the company's 2014 Integrated Performance Report. The company's first...
-
Dec 4, 2014
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Dec 4, 2014
MINNEAPOLIS AND DUBLIN, Ireland - Dec. 4, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Chinese Ministry of Commerce has cleared Medtronic's proposed...
-
Dec 4, 2014
MINNEAPOLIS AND DUBLIN, Ireland - Dec. 4, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the Chinese Ministry of Commerce has cleared Medtronic's proposed...
-
Dec 4, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Dec. 4, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Dec 4, 2014
MINNEAPOLIS - December 4, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.305 per share of the Company's common stock. The dividend is payable on...
-
Dec 1, 2014
MINNEAPOLIS - December 1, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the pricing of $17 billion aggregate principal amount of senior notes in seven tranches, as follows: Description Amount...
-
Nov 30, 2014First and Only DES with Novel CoreWire Technology Allows for Thinner, Stronger Struts, Enhanced Deliverability and Radiopacity without Compromising Structural Strength
MINNEAPOLIS - Nov. 3, 2014 - Optimizing the treatment of coronary artery disease with a new foundation for future stent innovations, Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Europé
-
Nov 28, 2014
MINNEAPOLIS AND DUBLIN, Ireland – Nov. 28, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced that the European Commission has conditionally cleared Medtronic’s...
-
Nov 26, 2014
MINNEAPOLIS AND DUBLIN, Ireland - Nov. 26, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance of...
-
Nov 24, 2014Fortrex™ PTA Balloon Facilitates Arteriovenous Access in Patients Receiving Hemodialysis for Chronic Kidney Disease
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 24, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for its Fortrex™ over-the-wire (OTW) percutaneous...
-
Nov 21, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 21, 2014-- Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the definitive joint proxy statement of Covidien plc and...
-
Nov 20, 2014New device is the only commercially available bedside monitor designed for home care and sleep study settings
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 20, 2014-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO2 Patient Monitoring System, PM100N. The system currently is...
-
Nov 19, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 19, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Nov 18, 2014Revenue of $4.4 Billion Grew 5% on Constant Currency Basis; 4% as Reported
MINNEAPOLIS - Nov. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2015, which ended October 24, 2014. The company reported worldwide...
-
Nov 17, 2014
MINNEAPOLIS AND DUBLIN - Nov. 17, 2014 - Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) announced that following a hearing today before the Irish High Court the companies have scheduled...
-
Nov 16, 2014Medtronic Studies Show Cardiac Resynchronization Therapy Extends Life, Reduces Hospital ReadmissionsData Demonstrate Clinical and Economic Value of Underutilized Treatment for Heart Failure Patients at American Heart Association's Scientific Sessions 2014
MINNEAPOLIS and CHICAGO - Nov. 16, 2014 - Medtronic, Inc. (NYSE: MDT) today announced new data supporting the clinical and economic value of its cardiac resynchronization therapy (CRT) devices for...
-
Nov 13, 2014
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 13, 2014Data Demonstrate Strong Closure Rates in Patients with Chronic Venous Insufficiency, Varicose Veins
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 13, 2014-- Covidien plc (NYSE:COV) today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the...
-
Nov 13, 2014
Covidien plc: IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT...
-
Nov 13, 2014Data Presented at Kidney Week 2014 Find Irregular Heartbeats Occur Frequently Around Hemodialysis Sessions
MINNEAPOLIS and PHILADELPHIA - Nov. 13, 2014 - Medtronic, Inc. (NYSE: MDT) today revealed the results of a new study which found that atrial fibrillation (AF) and bradycardia-two common heart...
-
Nov 12, 2014New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic Aneurysms
MINNEAPOLIS -- Nov. 12, 2014 -- The global leader in medical technology for endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT) today announced the launch in Europe and the United...
-
Nov 10, 2014Evera MRI(TM) ICD System Combines Proven Treatment Performance, Increased Longevity and Improved Comfort with Full-Body MRI Access
MINNEAPOLIS - Nov. 10, 2014 - Medtronic today announced Japanese regulatory approval and launch of the Evera MRI(TM) SureScan® implantable cardioverter-defibrillator (ICD) System for magnetic...
-
Nov 10, 2014
MINNEAPOLIS - Nov 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2015 on Tuesday, November 18, 2014. A news...
-
Nov 7, 2014
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Nov 5, 2014
MINNEAPOLIS, Nov. 5, 2014 - Today marks the launch of a new Harvard Business Review (HBR) Insight Center, exclusively sponsored by Medtronic, which provides a forum for thought-leading commentary,...
-
Nov 5, 2014Fourth-quarter net sales up 7%; Medical Devices sales up 8%
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 5, 2014-- Covidien plc (NYSE: COV) today announced financial results for the fourth quarter of fiscal 2014. Fourth-quarter net sales of $2.73 billion...
-
Nov 5, 2014EverFlex™ Self-Expanding Stent System Safe and Effective for the Treatment of Iliac Stenosis
LAS VEGAS--(BUSINESS WIRE)--Nov. 5, 2014-- Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex™ stent...
-
Nov 4, 2014Employee Engagement, Philanthropy Among Top Reasons for Selection
BRAMPTON, ONTARIO - November 4, 2014 - Medtronic of Canada Ltd., a trusted Canadian leader in innovative medical technologies and health system solutions, is pleased to have been recognized as one...
-
Nov 4, 2014Consistent Outcomes Despite Common and Challenging Comorbidity Reinforce Overall Findings of IN.PACT SFA Trial
LAS VEGAS -- Nov. 4, 2014 -- For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug-coated balloon from Medtronic, Inc. (NYSE: MDT) provided a...
-
Nov 4, 2014The HawkOne™ System strengthens Covidien’s directional atherectomy platform with a versatile solution for the treatment of peripheral arterial disease
DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 4, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the HawkOne™ directional atherectomy system. The...
-
Nov 4, 2014Results suggest long-term benefits for peripheral artery disease patients treated with directional atherectomy followed by a drug-coated balloon
LAS VEGAS--(BUSINESS WIRE)--Nov. 4, 2014-- Covidien plc (NYSE: COV) today announced 12-month results of the DEFINITIVE AR study, the first randomized study designed to identify the clinical...
-
Nov 2, 2014Expands Spectranetics' portfolio of solutions to treat complex vascular conditions in projected $700 million drug coated balloon segment
COLORADO SPRINGS, Colo., and DUBLIN, Ireland, Nov. 2, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) and Covidien plc (NYSE:COV) today announced a definitive agreement under...
-
Oct 30, 2014- Record 675 HeartWare® Ventricular Assist Systems sold worldwide in Q3
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Oct 28, 2014ReliaTack™ device delivers superior access, stronger fixation and lower cost of care for minimally invasive hernia repair
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 28, 2014-- Covidien plc (NYSE:COV) today announced the launch of ReliaTack™ articulating reloadable fixation device, the first and only of its kind for...
-
Oct 28, 2014
MINNEAPOLIS - October 28, 2014 - Medtronic, Inc. (NYSE: MDT) today announced it has initiated the PERIGON (PERIcardial SurGical AOrtic Valve ReplacemeNt) Pivotal Trial, a global, prospective...
-
Oct 27, 2014Covidien Launches Next-Generation SuperDimension™ Lung Navigation Software to Simplify Planning, Enhance Visualization During a Procedure
DUBLIN--(BUSINESS WIRE)--Oct. 27, 2014-- Further underscoring its ongoing commitment to lung health, Covidien (NYSE:COV) today unveiled a next-generation version of its superDimension™...
-
Oct 23, 2014Lung cancer is the number one cancer killer of women
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 23, 2014-- Covidien (NYSE: COV) is joining forces with the American Lung Association’s LUNG FORCE movement to raise awareness of the threat that lung...
-
Oct 21, 2014System Offers New Approach to Single-Level ACDF Procedures
MEMPHIS, TENN. - October 21, 2014 - Medtronic, Inc. (NYSE: MDT) announced the U.S. launch of the DIVERGENCE(TM) Anterior Cervical Fusion System for the treatment of single-level cervical disc...
-
Oct 21, 2014Covidien-World Stroke Organization Survey Shows Low Knowledge of Stroke Prevention, Treatment Options
Dublin, Ireland and Geneva – Oct. 22, 2014 – Despite its being the second leading cause of death worldwide, many people still do not recognize the threat stroke poses and the warning signs...
-
Oct 20, 2014
MEMPHIS, TENN., - October 20, 2014 - Medtronic, Inc. (NYSE: MDT) introduced its Pure Titanium Coating (PTC) platform of interbody fusion devices for the spine today at the 2014 Congress of...
-
Oct 17, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 17, 2014-- Covidien plc (NYSE: COV) today announced that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against...
-
Oct 15, 2014
HeartWare International, Inc. (NASDAQ: HTWR) has scheduled a conference call to discuss its financial results for the three months ended September 30, 2014, at 8:00 a.m. U.S. Eastern Daylight Time...
-
Oct 14, 2014In-Clinic Study Marks Critical Step Toward an Artificial Pancreas and Key Milestone Toward U.S. Commercialization
MINNEAPOLIS - October 14, 2014 - Medtronic, Inc. (NYSE:MDT) today announced that the first patients have been enrolled in an investigational device exemption (IDE) study of its breakthrough...
-
Oct 13, 2014Late-Breaking ADVANCE Direct Aortic Study Presented at EACTS Reaffirms CoreValve System's Positive Performance with Low Mortality and Stroke
MINNEAPOLIS and MILAN - Oct. 13, 2014 -Medtronic, Inc. (NYSE: MDT) today announced positive data from nine European centers in a study of the direct aortic approach (through the upper chest) with...
-
Oct 13, 2014Covidien Promotes Greater Global Awareness of Thrombosis Risks
October 13, 2014 12:01 AM Eastern Daylight Time DUBLIN, Ireland--(BUSINESS WIRE)--As part of a global effort to highlight the threat posed by venous thromboembolism (VTE), Covidien plc today...
-
Oct 10, 2014
Dublin, Ireland -- October 10, 2014 – Covidien today announced that it has notified customers of a voluntary Field Safety Alert for certain Medi-Trace™ Cadence and Kendall™ Multi-function...
-
Oct 10, 2014
MINNEAPOLIS -- October 10, 2014 -- Medtronic (NYSE: MDT) today announced the executive team who will lead the combined organization following the close of its proposed acquisition of Covidien. The...
-
Oct 10, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 10, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Oct 9, 2014Monitor is only portable oximeter on the market that is indicated for use in home care settings and is compliant with international standards for devices used in the home health care environment
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 9, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the Nellcor™ Portable SpO2 Patient Monitoring...
-
Oct 8, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 8, 2014-- Covidien plc: FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
-
Oct 7, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 7, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Oct 7, 2014FDA-Approved System Provides Patients with Added Benefits While Testing Innovative Therapy for Bladder and Bowel Incontinence
MINNEAPOLIS - October 7, 2014 - After living with overactive bladder and urinary retention symptoms for 11 years, Jennifer LaForest, a 26-year-old woman from Auburn Hills, Michigan, recently...
-
Oct 3, 2014Company reaffirms commitment to Covidien transaction
MINNEAPOLIS -October 3, 2014- Medtronic, Inc. (NYSE: MDT), a global leader in medical technology, services and solutions, today announced that it intends to use approximately $16 billion in...
-
Sep 30, 2014Despite prevalence of PAD symptoms, the majority of patients have not consulted a physician
DUBLIN, Ireland, Sep 30, 2014 (BUSINESS WIRE) --More than 40 percent of Americans aged 40 and older have experienced one or more of the most common symptomsi of peripheral arterial disease (PAD)....
-
Sep 29, 2014Building on Nearly a Decade of Growth, Partnership Allows Twin Cities In Motion to Continue to Expand and Enhance Race Events and Youth Programming
MINNEAPOLIS - Sept. 29, 2014 -Medtronic and Twin Cities In Motion, the organizers of the Medtronic Twin Cities Marathon, today announced a five-year, $2.5 million agreement that will keep...
-
Sep 25, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 25, 2014-- Covidien plc (NYSE: COV) will report fourth-quarter and fiscal 2014 results on November 5. The company will host a conference call for investors...
-
Sep 25, 2014$6 Million Marks the Largest Private-Sector Contribution to Date to Address One of the World's Most Neglected, Yet Preventable, Diseases Affecting the World's Poor
MINNEAPOLIS - September 25, 2014 - Medtronic today announced a five-year, $6 million (USD) funding commitment from Medtronic Philanthropy to reduce premature mortality resulting from Rheumatic...
-
Sep 24, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 24, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Sep 21, 2014
MINNEAPOLIS - Sept. 22, 2014 - Medtronic, Inc. (NYSE: MDT) has received CE (Conformité Européenne) Mark for the TYRX(TM) Absorbable Antibacterial Envelope. This innovative mesh envelope covers...
-
Sep 18, 2014Commitment to delivering innovative medical technologies creates most versatile cordless ultrasonic offering in the industry
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 18, 2014-- Covidien plc (NYSE:COV) today announced the expansion of its Sonicision™ Cordless Ultrasonic Dissection Device portfolio, following U.S. Food...
-
Sep 17, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 17, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 13% increase in the quarterly dividend rate, from $0.32 per...
-
Sep 17, 2014Enhancements Give Physicians More Options for Treating Vertebral Compression Fractures
MEMPHIS, TN - September 17, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the launch of the KYPHON Express(TM) II Balloon Kyphoplasty Platform, which includes the next generation KYPHON ®...
-
Sep 17, 2014
MINNEAPOLIS - Sept. 17, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that its Board of Directors elected Elizabeth Nabel, M.D., president of Brigham & Women's Hospital and Brigham & Women's...
-
Sep 16, 2014New Data from the OpT2mise Efficacy Study to be Presented at EASD Annual Meeting
VIENNA - September 16, 2014 - Medtronic, Inc. (NYSE:MDT) today announced that new results from the OpT2mise trial are being presented at the European Association for the Study of Diabetes (EASD) 50th
-
Sep 16, 2014IN.PACT Global Study Reports Favorable Outcomes in Real-World Patient Population and Validates Key Findings from IN.PACT SFA Trial
WASHINGTON -- Sept. 16, 2014 -- Presented for the first time at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) conference, the latest clinical and economic data on the IN.PACT Admiral...
-
Sep 15, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 15, 2014-- Covidien plc announced today the start of enrollment in two clinical trials designed to further underscore the safety and effectiveness of the...
-
Sep 15, 2014New External Heart Monitor and Remote Monitoring Center Help Patients Find Answers to Unexplained Cardiac Symptoms
MINNEAPOLIS - September 15, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. launch of the SEEQ(TM) Mobile Cardiac Telemetry (MCT) System, an external, wire-free, adhesive heart monitor...
-
Sep 13, 2014Cost Effectiveness of Self-Expanding Valve Driven by Improved Quality of Life Benefit and Superior One-Year Survival Rates over Surgical Aortic Valve Replacement
WASHINGTON, D.C., and MINNEAPOLIS - Sept. 13, 2014 - In the first-ever in-trial cost effectiveness analysis of transcatheter aortic valve replacement (TAVR) for patients at high risk for surgery,...
-
Sep 13, 2014TCT Late-Breaking First Report Reveals High Survival, Low Stroke Rates and Sustained Valve Performance
WASHINGTON, D.C. and MINNEAPOLIS - Sept. 13, 2014 - Medtronic, Inc. (NYSE: MDT) today announced new data showing that transcatheter aortic valve replacement (TAVR) with the CoreValve® System...
-
Sep 11, 2014Superior Deliverabilityi and Uncompromising Performance Distinguishes New Angioplasty Balloon
MINNEAPOLIS -- Sept. 11, 2014 -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) 510(k) clearance and launch of the NC Euphora(TM) Noncompliant Balloon...
-
Sep 11, 2014
MINNEAPOLIS - Sept. 11, 2014 - Medtronic, Inc. (NYSE: MDT) was recognized as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability World Index...
-
Sep 10, 2014First Patients Successfully Treated in Study to Evaluate Next Generation Transcatheter Valve
MINNEAPOLIS - Sept. 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate the safety and effectiveness of the...
-
Sep 3, 2014Next-Generation TAVI System Offers Ability to Recapture and Reposition During Deployment
MINNEAPOLIS - Sept. 3, 2014 - Medtronic, Inc. (NYSE: MDT) today announced CE (Conformité Européene) Mark for the 23 mm CoreValve® Evolut(TM) R System for transcatheter aortic valve implantation...
-
Sep 2, 2014
MINNEAPOLIS - Sept 2, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Morgan Stanley Global Healthcare Conference,...
-
Aug 28, 2014Transaction expands Covidien’s market leading portfolio with next generation technology for treatment of varicose veins
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 28, 2014-- Covidien plc (NYSE: COV) today announced that it has acquired Sapheon, Inc., a privately-held developer of venous disease treatments. Financial...
-
Aug 28, 2014First U.S. Growth Guidance System Cleared to Treat Scoliosis with Children's Needs in Mind
MEMPHIS, TN - Aug. 28, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the 510(k) clearance and launch of the SHILLA(TM) Growth Guidance System. The system is designed for treatment of...
-
Aug 27, 2014NGC's Hospital Managed Services Business Adds to Medtronic's Growing Healthcare Services and Solutions Portfolio
TOLOCHENAZ - August 27, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of NGC Medical S.p.A. (NGC), a privately-held Italian company, in a transaction...
-
Aug 27, 2014Post-Market Clinical Trial Will Assess Superiority of the AdaptivCRT® Feature Compared to Standard CRT
MINNEAPOLIS - Aug. 27, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including patient...
-
Aug 26, 2014Sapiens' Deep Brain Stimulation Technologies Strengthen Medtronic's Neuromodulation Portfolio and Neuroscience Leadership Position
MINNEAPOLIS and EINDHOVEN - Aug. 26, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep...
-
Aug 26, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 26, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
-
Aug 25, 2014AdaptivCRT® Algorithm Customizes Therapy for Heart Failure Patients and Improves Their Response Rates
MINNEAPOLIS - Aug. 25, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva®...
-
Aug 22, 2014Generates Opportunity to Leverage Existing Vascular Technologies and Customer Relationships to Drive Increased Market Penetration
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 22, 2014-- Covidien plc (NYSE:COV) today announced it has acquired Reverse Medical Corporation, a privately held medical device company focused on expanding...
-
Aug 21, 2014
MINNEAPOLIS - August 21, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.305 per share of the company's common stock. The quarterly dividend...
-
Aug 21, 2014
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 21, 2014-- Covidien plc (NYSE: COV) today announced that the U.S. Food and Drug Administration (FDA) has approved changes to the manufacturing process for...
-
Aug 20, 2014Facility offers educational resources, research capabilities
SÃO PAULO--(BUSINESS WIRE)--Aug. 20, 2014-- Covidien plc (NYSE: COV) today officially opened its Covidien Center of Innovation Brazil (CCI Brazil), further expanding its educational and research...
-
Aug 20, 2014
MINNEAPOLIS - August 20, 2014 - Greater Twin Cities United Way today strengthened their long-standing commitment to improving the health and well-being of Twin Cities' communities by teaming up...
-
Aug 19, 2014Revenue of $4.3 Billion Grew 4% on Constant Currency Basis; 5% as Reported
MINNEAPOLIS - Aug. 19, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2015, which ended July 25, 2014. The company reported worldwide...
-
Aug 18, 2014Largest directional atherectomy study with independent, core lab analysis demonstrates high limb salvage in patients with critical limb ischemia and strong patency rates in both diabetic and claudicant patients
DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 18, 2014-- Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a...
-
Aug 11, 2014Distance Runners from Around the World Who Benefit from Medical Technology to Run Medtronic Twin Cities Marathon Events this Fall
MINNEAPOLIS - August 11, 2014 - Twenty-five long-distance runners who benefit from medical technology will be honored as "Medtronic Global Heroes" when they run as a team in the Medtronic Twin...
-
Aug 11, 2014
MINNEAPOLIS - Aug. 11, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the first quarter of its fiscal year 2015 on Tuesday, August 19, 2014. A news release...
-
Aug 7, 2014New System Helps Physicians Deliver Cardiac Resynchronization Therapy Optimally and Efficiently to Heart Failure Patients
MINNEAPOLIS - Aug. 7, 2014 - Medtronic, Inc. (NYSE: MDT) today announced it has received United States Food and Drug Administration (FDA) approval for the Attain Performa® Model 4298 quadripolar...
-
Aug 5, 2014
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Aug 4, 2014
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
-
Aug 1, 2014System Offers Innovative Technology for Sinus Surgery. Chronic Sinusitis Affects Nearly 29 Million US Adults
MINNEAPOLIS - August 1, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the launch of the NuVent(TM) EM Sinus Dilation System for the Fusion® ENT Navigation System, developed and manufactured...
-
Jul 31, 2014- Record 674 HeartWare® Ventricular Assist Systems sold worldwide in Q2
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...